权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Multidisciplinary Educational Approach to Reducing Cancer Disparities

减少癌症差异的多学科教育方法

基本信息

批准号：
10246272
负责人：
Jorge Silvio Gutkind
金额：
$ 34.6万
依托单位：
UNIVERSITY OF CALIFORNIA, SAN DIEGO
依托单位国家：
美国
项目类别：
财政年份：
2019
资助国家：
美国
起止时间：
2019-09-01 至 2024-08-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10246272
关键词：
Achievement Address Admission activity Awareness Behavioral Biological Biomedical Research California Cancer Burden Cancer Center Cancer Control Cancer Control Research Clinical Collaborations Color Communities Community Outreach Country Cultural Backgrounds Databases Dentistry Development Discipline Discipline of Nursing Drops Educational Background Educational Status Educational workshop Engineering Enrollment Ethnic group Event Exposure to Gender Geography Goals Health Health Sciences Individual Institutes Interdisciplinary Study Intervention Laboratories Learning Literature Malignant Neoplasms Medical Medicine Mentors Molecular Biology Monitor Morbidity - disease rate NCI-Designated Cancer Center Nanotechnology National Cancer Institute Oncology Participant Pathway interactions Pharmacology Play Population Psychology Public Health Public Speaking Race Research Research Activity Research Personnel Resolution Review Literature Role STEM program Schedule Schools Science Science, Technology, Engineering and Mathematics Secure Sex Orientation Solid Student recruitment Students Subgroup Time Time Management Training Underrepresented Students United States United States National Institutes of Health Universities Woman Work Writing Youth academic preparation age group base biobehavior cancer genetics cancer health disparity career clinical care design drug discovery education research experience faculty research hands on research hands-on learning health disparity innovation laboratory experience learning strategy meetings mortality multidisciplinary programs recruit religious group science education skills socioeconomic disadvantage socioeconomics success symposium theories training opportunity translational cancer research tumor registry undergraduate student

项目摘要

PROJECT SUMMARY/ABSTRACT Increasing the diversity of cancer researchers and clinicians is a key strategy for finding innovative cancer control solutions and reducing cancer disparities. This Youth Enjoy Science Research Education (YES) Program will increase the diversity of University of California San Diego (UCSD) graduates who are pursuing graduate/professional training in the sciences. This YES Program is grounded on the Transformative Learning Theory and UCSD's 16 years of experience conducting UCSD's successful CURE Program. This YES Program will increase the number of women and underrepresented students from diverse scientific disciplines who are prepared for graduate school admission, with a focus on addressing cancer and cancer disparities. Specifically, YES students participate in classroom and laboratory learning activities that raise their understanding of cancer and the nation's and the world's cancer disparities. Thus, cancer disparities and how they are identified and resolved become the common theme that interconnects this YES Program's various learning activities. Students approach the issues related to cancer disparities, from the perspective of their individual laboratory training, classes and workshops, their own cultural backgrounds, community outreach events they deploy, and their chosen academic and professional pathways. San Diego's three NCI-designated cancer centers (UCSD, Salk Institute for Biological Studies, and Sanford Burnham Prebys Medical Discovery Institute) invite the YES students to work and learn in the basic, behavioral, clinical and translational cancer research labs of their top cancer researchers. In their labs and classrooms, the YES students gain a solid understanding of cancer and the many bio-behavioral issues related to the development and exacerbation of cancer disparities and the possible resolutions. With this information and their literature review, students learn how to work on multidisciplinary teams as they develop programs to help reduce their community's cancer morbidity and mortality rates. Through these activities, students learn that, throughout their lives, they can play a role in reducing cancer disparities. To help YES students' reach their full academic, personal, and professional potential, they are also offered supplementary learning experiences, e.g., public speaking, goal setting and time management, writing, conducting literature search and synthesis skills, and experiences presenting and discussing their research work with professional and lay audiences. Students also prepare and submit abstracts to present their research findings at research symposia and national scientific meetings. Mentoring of the YES Program students, continues throughout their time at UCSD and on to graduate school. Thus, the premise of this YES program is that this learning opportunity will give the students hands-on research experiences and skills that will help them to secure admission to graduate level STEM programs and careers in cancer control research, always with a focus on reducing cancer disparities.

项目总结/摘要增加癌症研究人员和临床医生的多样性是寻找创新癌症的关键策略控制解决方案和减少癌症差异。这个年轻人享受科学研究教育（是）该计划将增加加州圣地亚哥大学（UCSD）毕业生的多样性，科学领域的研究生/专业培训。这个YES计划是基于变革性学习理论和UCSD的16年经验进行UCSD的成功治愈计划。这是YES 该计划将增加来自不同科学学科的女性和代表性不足的学生人数谁准备研究生院录取，重点是解决癌症和癌症的差距。具体来说，YES学生参加课堂和实验室学习活动，提高他们的了解癌症以及国家和世界癌症的差异。因此，癌症的差异以及它们被识别和解决成为连接这个YES计划的各种学习活动。学生们从他们的角度出发，探讨与癌症差异相关的问题。个人实验室培训、课程和讲习班、他们自己的文化背景、社区外展他们部署的活动，以及他们选择的学术和专业途径。圣地亚哥的三个国家癌症研究所指定的癌症中心（加州大学圣地亚哥分校，索尔克生物研究所，和桑福德伯纳姆Prebys医学发现研究所）邀请YES学生在基础，行为，临床和转化癌症方面工作和学习顶尖癌症研究人员的研究实验室在他们的实验室和教室里，YES学生获得了坚实的了解癌症以及与癌症发展和恶化相关的许多生物行为问题，癌症的差异和可能的解决方案。有了这些信息和他们的文献回顾，学生们学习如何与多学科团队合作，制定帮助减少社区癌症的计划发病率和死亡率。通过这些活动，学生们了解到，在他们的一生中，他们可以玩在减少癌症差异方面发挥作用。为了帮助YES学生达到他们完整的学术，个人和专业潜力，他们还提供补充学习经验，例如，公开演讲，目标设置和时间管理，写作，进行文献检索和综合技能，和经验介绍和讨论他们的研究工作与专业和外行观众。学生们还准备和提交摘要，在研究研讨会和国家科学会议上介绍其研究成果。 YES计划学生的指导，继续在UCSD和研究生院的整个时间。因此，这个YES计划的前提是，这个学习机会将给学生动手研究经验和技能，这将有助于他们获得研究生水平的STEM课程录取，癌症控制研究的职业生涯，始终专注于减少癌症差异。